FDA Inspection 1158849 — Aphena Pharma Solutions - Maryland, LLC
The FDA completed an inspection of Aphena Pharma Solutions - Maryland, LLC on December 15, 2021 in Easton, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 15, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Easton, MD (United States)